Kidney involvement of chronic active Epstein‐Barr virus infection

por Fukumoto, Ami, Sugihara, Shinnosuke, Seki, Kurumi, Takeuchi, Masami, Suzuki, Tomo, Kosei, Matsue
Publicado 2023

P1547: CLINICAL CHARACTERISTICS OF PATIENTS WITH PROLONGED VIRAL SHEDDING OF OMICRON VARIANT IN HAEMATOLOGICAL DISEASE

por Ikeda, Daisuke, Narita, Kentaro, Fukumoto, Ami, Uesugi, Yuka, Tabata, Rikako, Miura, Daisuke, Takeuchi, Masami, Matsue, Kosei
Publicado 2023

P1137: COMBINED METABOLIC HETEROGENEITY AND TOTAL LESION GLYCOLYSIS FROM PET-CT IMPROVES THE PROGNOSTIC STRATIFICATION IN PATIENTS WITH PERIPHERAL T-CELL LYMPHOMA

por Ikeda, Daisuke, Fukumoto, Ami, Uesugi, Yuka, Tabata, Rikako, Miura, Daisuke, Narita, Kentaro, Takeuchi, Masami, Machida, Yoichi, Matsue, Kosei
Publicado 2023

Clinical and immunological characteristics of prolonged SARS-CoV-2 Omicron infection in hematologic disease

por Ikeda, Daisuke, Fukumoto, Ami, Uesugi, Yuka, Tabata, Rikako, Miura, Daisuke, Narita, Kentaro, Takeuchi, Masami, Watari, Tomohisa, Otsuka, Yoshihito, Matsue, Kosei
Publicado 2023

Antibody response to COVID-19 vaccine in 130 recipients of hematopoietic stem cell transplantation

por Tsushima, Takafumi, Terao, Toshiki, Narita, Kentaro, Fukumoto, Ami, Ikeda, Daisuke, Kamura, Yuya, Kuzume, Ayumi, Tabata, Rikako, Miura, Daisuke, Takeuchi, Masami, Matsue, Kosei
Publicado 2022

Prevalence and Clinical Outcome of Omicron Breakthrough Infection in Patients With Hematologic Disease: A Prospective Observational Cohort Study

por Narita, Kentaro, Ikeda, Daisuke, Seki, Mizuki, Fukumoto, Ami, Tabata, Rikako, Uesugi, Yuka, Miura, Daisuke, Takeuchi, Masami, Doi, Masahiro, Umezawa, Yuka, Otsuka, Yoshihito, Matsue, Kosei
Publicado 2023

Association of loss of spleen visualization on whole-body diffusion-weighted imaging with prognosis and tumor burden in patients with multiple myeloma

por Terao, Toshiki, Machida, Youichi, Tateishi, Ukihide, Tsushima, Takafumi, Narita, Kentaro, Ikeda, Daisuke, Fukumoto, Ami, Kuzume, Ayumi, Tabata, Rikako, Miura, Daisuke, Takeuchi, Masami, Matsue, Kosei
Publicado 2021

Impaired Antibody Response Following the Second Dose of the BNT162b2 Vaccine in Patients With Myeloproliferative Neoplasms Receiving Ruxolitinib

por Ikeda, Daisuke, Terao, Toshiki, Miura, Daisuke, Narita, Kentaro, Fukumoto, Ami, Kuzume, Ayumi, Kamura, Yuya, Tabata, Rikako, Tsushima, Takafumi, Takeuchi, Masami, Hosoki, Takaaki, Matsue, Kosei
Publicado 2022

Humoral Response to the Third-Dose COVID-19 Vaccination in Patients with Hematological Malignancy

por Ikeda, Daisuke, Terao, Toshiki, Fukumoto, Ami, Kuzume, Ayumi, Kamura, Yuya, Tabata, Rikako, Tsushima, Takafumi, Miura, Daisuke, Narita, Kentaro, Takeuchi, Masami, Yamashita, Takeshi, Takamatsu, Hiroyuki, Matsue, Kosei
Publicado 2022

Antibody response to COVID-19 vaccination in patients with lymphoma

por Narita, Kentaro, Nakaji, So, Tabata, Rikako, Terao, Toshiki, Kuzume, Ayumi, Tsushima, Takafumi, Ikeda, Daisuke, Fukumoto, Ami, Miura, Daisuke, Takeuchi, Masami, Doi, Masahiro, Umezawa, Yuka, Otsuka, Yoshihito, Takamatsu, Hiroyuki, Matsue, Kosei
Publicado 2022

Low clinical protective response to SARS-CoV-2 mRNA COVID-19 vaccine in patients with multiple myeloma

por Terao, Toshiki, Yamashita, Takeshi, Fukumoto, Ami, Kamura, Yuya, Ikeda, Daisuke, Kuzume, Ayumi, Tabata, Rikako, Tsushima, Takafumi, Miura, Daisuke, Narita, Kentaro, Takeuchi, Masami, Doi, Masahiro, Umezawa, Yuka, Otsuka, Yoshihito, Takamatsu, Hiroyuki, Matsue, Kosei
Publicado 2022